AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells

The activation of bypass signals, such as MET and AXL, has been identified as a possible mechanism of EGFR-TKI resistance. Because various oncoproteins depend on HSP90 for maturation and stability, we investigated the effects of AUY922, a newly developed non-geldanamycin class HSP90 inhibitor, in lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yun Jung, Kim, Seon Ye, So, Kwang Sup, Baek, In-Jeoung, Kim, Woo Sung, Choi, Se Hoon, Lee, Jae Cheol, Bivona, Trever G., Rho, Jin Kyung, Choi, Chang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363657/
https://www.ncbi.nlm.nih.gov/pubmed/25780909
http://dx.doi.org/10.1371/journal.pone.0119832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363657/
https://www.ncbi.nlm.nih.gov/pubmed/25780909
http://dx.doi.org/10.1371/journal.pone.0119832

Ejemplares similares